Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-01-13 @ 7:45 AM
Study NCT ID:
NCT04058158
Status:
COMPLETED
Last Update Posted:
2024-03-26
First Post:
2019-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haemoglobinuria
Sponsor:
Samsung Bioepis Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-21
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-12
First Submit QC Date:
None
Study First Post Date:
2019-08-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-14
Results First Submit QC Date:
None
Results First Post Date:
2024-03-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-25
Last Update Post Date:
2024-03-26
Last Update Post Date Type:
ACTUAL